Pressure Biosciences Inc (PBIO) Gross Profit Margin starting from the second quarter 2024 to second quarter 2023, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Gross Margin
• EBITDA Margin
• Operating Margin
• Net Margin
• Pre-Tax Margin
• Effective Tax Rate
• Free Cash Flow Margin
• Cash Flow Margin
Pressure Biosciences Inc   (PBIO)


Pressure Biosciences Inc 's Gross Profit Margin by quarter

Trends, Rankings, Statistics


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

PBIO Gross Profit Margin (Jun 30 2024)
Q2 		(Mar 31 2024)
Q1 		(Dec 31 2023)
Q4 		(Sep 30 2023)
Q3 		(Jun 30 2023)
Q2
Y / Y Revenue Change -17.59 %
Seq. Revenue Change 20.77 %
Revenue In Millions $0.42
Gross Profit Margin 10.49 %
Gross Profit Margin Total Ranking # 3487
Gross Profit In Millions $0.04
Y / Y Gross Profit Change -82.66 %
Seq. Gross Profit Change -61.84 %


Commenting Second Quarter 2024 Gross Profit Margin
Company's Gross Profit Margin sequentially deteriorated to 10.49 % due to increase in Cost of Sales and despite Revenue increase of 20.77 % to $0 millions.
Pressure Biosciences Inc achieved highest Gross Profit Margin in II. Quarter


Observing second quarter 2024 results within Laboratory Analytical Instruments industry 25 other companies have achieved higher Gross Profit Margin. While Gross Profit Margin overall ranking has deteriorated relative to the three months before, from 2582 to 3487.
Learn about Gross Margin
PBIO's Gross Profit Margin second quarter 2024 Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 26
Healthcare Sector # 475
Overall # 3442

Gross Profit Margin Statistics
High Average Low
84.33 % 47.69 % 10.49 %
(Dec 31 2020)   (Jun 30 2024)


PBIO Gross Income Trends • More of PBIO's Profitabilty Ratios • PBIO Stock Quotes and Charts


Other Gross Profit Margin Profitability Ratios
PBIO's Cumulative Gross Profit Margin
Laboratory Analytical Instruments Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
PBIO's Gross Profit Margin Profitability versus Laboratory Analytical Instruments Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for PBIO's Competitors
Gross Profit Margin Profit Margin for Pressure Biosciences Inc 's Suppliers
Gross Profit Margin Profit Margin for PBIO's Customers

You may also want to know
PBIO's Annual Growth Rates PBIO's Profitability Ratios PBIO's Asset Turnover Ratio PBIO's Dividend Growth
PBIO's Roe PBIO's Valuation Ratios PBIO's Financial Strength Ratios PBIO's Gross Profit Growth
PBIO's Roa PBIO's Inventory Turnover Ratio PBIO's Growth Rates PBIO's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Jun 30 2024, within Laboratory Analytical Instruments Industry Gross Profit MarginJun 30 2024 MRQ Gross ProfitJun 30 2024 MRQ Revenue
Kewaunee Scientific Corporation  26.30 %$ 12.488  Millions$ 47.488  Millions
Rapid Micro Biosystems Inc   25.70 %$ 1.701  Millions$ 6.618  Millions
Accelerate Diagnostics Inc   25.26 %$ 0.676  Millions$ 2.676  Millions
Pacific Biosciences Of California Inc   16.52 %$ 5.938  Millions$ 35.938  Millions
Pressure Biosciences Inc   10.49 %$ 0.044  Millions$ 0.422  Millions




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.